COGT financials
Cogent Biosciences (COGT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
COGT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$4.62M | -$333.36M | -$328.94M | -2.04 |
| 2024 | $0.00 | $0.00 | -$275.94M | -$255.86M | -2.32 |
| 2023 | $0.00 | $0.00 | -$208.13M | -$192.41M | -2.42 |
| 2022 | $0.00 | $0.00 | -$147.84M | -$140.24M | -2.26 |
| 2021 | $0.00 | $0.00 | -$75.55M | -$72.27M | -1.85 |
| 2020 | $7.87M | -$17.87M | -$82.20M | -$74.81M | -6.00 |